IGF1 and retinopathy of prematurity: Recently, a randomized, multicenter (phase IIb) clinical trial of continuous infusion of rhIGF-1 has been launched to address whether maintaining normal physiological levels of IGF-1 may prevent ROP (and other neonatal complications) in premature infants (NCT01096784).